524717 TITANBIO

Titan Biotech Share Price

₹763.05 +30.3 (4.14%)

02 Jan, 2025 00:51

SIP TrendupStart SIP in TITANBIO

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month -0.53%
  • Over 3 Month + 7.49%
  • Over 6 Month + 25.13%
  • Over 1 Year + 86.29%
SIP Lightning

Smart Investing Starts Here Start SIP with Titan Biotech for Steady Growth!

Invest Now

Titan Biotech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Titan Biotech Financials

Titan Biotech Technicals

EMA & SMA

Current Price
₹763.05
+ 30.3 (4.14%)
pointer
  • stock-down_img
  • Bullish Moving Average 10
  • stock-up_img
  • Bearish Moving Average 6
  • 20 Day
  • ₹768.52
  • 50 Day
  • ₹780.81
  • 100 Day
  • ₹745.67
  • 200 Day
  • ₹666.81

Resistance and Support

753.52 Pivot Speed
  • R3 806.88
  • R2 785.92
  • R1 774.48
  • S1 742.08
  • S2 721.12
  • S3 709.68

What's your outlook on Titan Biotech?

You can only vote for once

Titan Biotech Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-12 Quarterly Results
2024-08-13 Quarterly Results
2024-05-29 Audited Results
2024-02-12 Quarterly Results
2023-11-08 Quarterly Results

Titan Biotech F&O

Titan Biotech Shareholding Pattern

No data available.

About Titan Biotech

  • NSE Symbol
  • TITANBIO
  • BSE Symbol
  • 524717
  • ISIN
  • INE150C01011

Similar Stocks to Titan Biotech

Titan Biotech FAQs

Titan Biotech share price is ₹763 As on 02 January, 2025 | 00:37

The Market Cap of Titan Biotech is ₹630.6 Cr As on 02 January, 2025 | 00:37

The P/E ratio of Titan Biotech is 25 As on 02 January, 2025 | 00:37

The PB ratio of Titan Biotech is 4.7 As on 02 January, 2025 | 00:37

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23